Nagasawa, Ryosuke https://orcid.org/0009-0002-0474-3218
Onizuka, Kazumitsu https://orcid.org/0000-0001-9713-4619
Komatsu, Kaoru R. https://orcid.org/0000-0002-4505-0840
Miyashita, Emi
Murase, Hirotaka https://orcid.org/0000-0001-5747-191X
Ojima, Kanna
Ishikawa, Shunya
Ozawa, Mamiko
Saito, Hirohide https://orcid.org/0000-0002-8570-5784
Nagatsugi, Fumi https://orcid.org/0000-0002-5526-6020
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP20H02855, JP21K19038, JP20H04762, JP23H04051, JP19H02845, JP17H05601, JP20H05626, JP19K22387)
MEXT | Japan Science and Technology Agency (JPMJSP2114, JPMJFR2002)
Takeda Science Foundation
Uehara Memorial Foundation
Noguchi Foundation Tokyo Biochemical Research Foundation
Naito Foundation
Mitsubishi Foundation
Article History
Received: 20 September 2023
Accepted: 17 April 2024
First Online: 1 May 2024
Competing interests
: K.R.K. and H.S. own shares of xFOREST Therapeutics Co., Ltd. All other authors declare no competing interests.